IMP: Approving plan for share issuance to increase charter captial

Approving plan for share issuance to increase charter captial of Imexpharm Corporation as follows: 

HOSE

>   IMP: Plan for share issuance to increase charter captial (06/09/2024)

>   IMP: Share issuance to increase charter capital from the owners' equity (06/09/2024)

>   BID121027: Information Disclosure on the Audit Report on the use of proceeds from bond issuance for outstanding bonds as of June 30, 2024 (05/09/2024)

>   RAL: Report on using capital from the share public offering (05/09/2024)

>   VCI: Notice of the correction of share issuance for capital increase from the owner’s equity (05/09/2024)

>   VIB: Result of the ESOP (05/09/2024)

>   SSI: Dividend payment & share issuance (05/09/2024)

>   DGW: Notice of stock issuance for the dividend payment (05/09/2024)

>   GEX: Approving the result of share issuance under ESOP (05/09/2024)

>   GEX: Result of stock issuance under ESOP (05/09/2024)